Articles about Pfizer

Scientists in South Africa have found that new Omicron subvariants—BA.4 and BA.5—are capable enough to evade immunity and trigger a new COVID-19 wave, Reuters reported.

Pfizer and BioNTech have begin the clinical trial for a vaccine against the Omicron variant of coronavirus, the companies said on Tuesday.

Early studies on the Omicron variant of coronavirus reportedly present a less grim picture than previously imagined.

Seven COVID-19 vaccines are safe and stimulate a strong immune response when used as a booster jab to those who have already vaccinated, a study published in The Lancet said.

India on Wednesday reported over 10,000 new COVID-19 cases with an active caseload of 1.28 lakh, the lowest in 527 days.

India is reportedly likely to approve Merck's anti-COVID-19 drug molnupiravir soon.

American company Pfizer's experimental antiviral pill to treat COVID-19 cuts the risk of hospitalization and death by 89% in vulnerable adults, according to clinical trial results.

Several antiviral drugs are being developed and tested for COVID-19 treatment as scientists around the world race to find new methods to fight the pandemic and ease the burden on hospitals.

Biopharmaceutical company Pfizer on Monday said that it has started middle-to-late stage clinical trial of an anti-COVID-19 pill to tackle the disease.

Sri Lanka has decided to ask for a $100 million loan from IMF to procure 14 million doses of Pfizer COVID-19 vaccine and finance other vaccination program-related costs, it was announced on Wednesday.

The COVID-19 vaccine developed by Pfizer and BioNTech has been found safe for children between five to 11 years of age and generates a "robust" immune response, the companies said on Monday.

School children aged between 12 and 15 years will be offered a first dose of the Pfizer/BioNTech COVID-19 vaccine starting next week, the UK government has announced after the country's Chief Medical Officers gave their go-ahead for the jabs for younger age groups.

Amid surging Delta variant cases in the USA, COVID-19 vaccines for children younger than 12 years could be available by the end of next month, a media report has said.

Breastfeeding mothers vaccinated with Pfizer or Moderna preventive experienced similar side effects to what have previously been reported in non-breastfeeding women, while infants exhibited no adverse events after immunization, a study has found.

COVID-19 antibodies generated by the Pfizer vaccine dipped by more than 80% six months after the second dose, a study conducted in the United States has found.

The Pfizer-BioNTech COVID-19 vaccine has finally received full approval from the US Food and Drug Administration (FDA) on Monday for use in people aged 16 and above in the country.

The United States Food and Drug Administration (FDA) is reportedly set to grant full approval to Pfizer-BioNTech's two-dose COVID-19 vaccine next week, expediting the previous timeline for licensing the vaccine.

COVID-19 vaccines developed by Pfizer and AstraZeneca are less effective against the Delta variant of the coronavirus, compared to the Alpha variant, a study led by researchers at the University of Oxford said.

Researchers have found no evidence of the presence of Pfizer or Moderna COVID-19 vaccines in breast milk suggesting that mRNA preventives are safe during lactation.

Two doses of the Pfizer COVID-19 vaccine induce a "very good" antibody response against the SARS-CoV-2 variants, according to a study on 180 health care workers in Finland.

In most coronavirus vaccination regimes, two doses of the same brand are given a few weeks apart.

A single dose of Pfizer or AstraZeneca COVID-19 vaccine offers around 60 percent protection against infection from SARS-CoV-2 in adults aged 65 years and above, according to a study published in The Lancet Infectious Diseases.

Pfizer and AstraZeneca vaccines provide good protection against the Delta variant of coronavirus, first identified in India, says a study published in The Lancet Journal.

The Indian government wants to soon start inoculating children against the coronavirus. However, there is no vaccine for that group yet.

The United States is buying 500 million doses of the Pfizer coronavirus vaccine to donate them among nearly 100 countries by the next year, top American newspapers have reported.

India does not have a coronavirus vaccine for children as yet.

The United Kingdom on Friday decided to approve the COVID-19 vaccine developed by Pfizer-BioNTech for use among those aged 12-15 years.

The Serum Institute of India has requested the Indian government to provide it indemnity from liability in connection with its COVID-19 vaccines, company sources cited by NDTV and The Hindu say.

The world's leading COVID-19 vaccines, including the ones from Pfizer and Moderna, may offer lasting protection that diminishes the need for frequent booster shots.

Israel has flagged a possible link between the COVID-19 vaccine developed by Pfizer-BioNTech and cases of heart inflammation (myocarditis), observed mainly in young men.

The Drugs Controller General of India has scrapped the requirement of local trials for foreign-made coronavirus vaccines - a key move to upscale the dwindling COVID-19 vaccinations in the country.

Delhi Chief Minister Arvind Kejriwal on Thursday sought procurement of Pfizer COVID-19 vaccine as soon as possible to inoculate children.

Pfizer has told the Indian government that its coronavirus vaccine shows "high effectiveness" on the COVID-19 variant prevalent in India as well as on people of Indian ethnicity or nationality.

India may not receive doses of the COVID-19 vaccines developed by Pfizer and Moderna until 2023 as the manufacturers have other commitments.

American pharmaceutical companies Pfizer and Moderna have said they would not sell their coronavirus vaccines directly to the Delhi government, Chief Minister Arvind Kejriwal revealed today.

Delay in giving a second dose of the Pfizer COVID-19 vaccine by 12 weeks increases antibody response in older people by three-and-a-half times compared to those who receive it at a three-week interval, according to a study conducted in the UK.

At a time when India is facing an acute shortage of COVID-19 vaccines, the Centre is in "high-level" discussions with American pharmaceutical giant Pfizer, which is likely to sell 50 million doses of its vaccine in India by the third quarter of this year.

In the biggest indication that the United States is fast returning to pre-pandemic life, the Centers for Disease Control and Prevention (CDC) has said fully vaccinated people are no longer required to wear masks.

A single dose of AstraZeneca's COVID-19 vaccine results in an 80% less risk of death from the viral infection, Public Health England (PHE), the executive agency of the UK department of health, said on Monday, citing data from the vaccine's rollout.

COVID-19 vaccines finally are headed for more kids as US regulators on Monday expanded the use of Pfizer's shot to those as young as 12, sparking a race to protect middle and high school students before they head back to class.